[Heavy chain disease]

Area of Science:

• Immunology
• Hematology
• Oncology

Context:

• Heavy chain diseases (HCDs) are a group of rare lymphoproliferative disorders.
• These conditions are defined by the production of monoclonal, incomplete immunoglobulin heavy chains lacking light chains.
• HCDs encompass gamma-HCD, alpha-HCD, and mu-HCD, each with distinct characteristics.

Purpose:

• To describe the characteristics and clinical presentations of various heavy chain diseases.
• To differentiate between the subtypes of HCDs based on their affected immunoglobulin class and clinical patterns.
• To highlight recent associations of heavy chain abnormalities with amyloidosis and deposition diseases.

Summary:

• Heavy chain diseases (HCDs) are characterized by the synthesis of truncated heavy chains without associated light chains.
• Gamma-HCD exhibits variable clinical features, whereas alpha-HCD predominantly affects the secretory IgA system and the digestive tract with a uniform clinical pattern.
• Alpha-HCD is the most prevalent subtype, while mu-HCD is rare and may be indicated by Bence Jones proteins and specific bone marrow findings.
• Recent research has linked molecular abnormalities of heavy chains to heavy-chain-associated amyloidosis and heavy chain deposition disease.

Impact:

• Provides a comprehensive overview of HCDs, aiding in their diagnosis and classification.
• Enhances understanding of the specific clinical manifestations of alpha-HCD, facilitating targeted patient management.
• Contributes to the differential diagnosis of lymphoproliferative disorders and related conditions like amyloidosis.